Micro-Sphere increases capsule filling capacity8 Oct 2018
The MG2 Tekna increases the CDMO’s manufacturing capacity to up to 500 million capsules per year.
Switzerland-based CDMO Micro-Sphere has announced that its MG2 Tekna capsule filling machine is now online, adding further strength to its offering in encapsulation for inhalation products.
Situated in a dedicated cleanroom at Micro-Sphere’s recently expanded facility near Lugano in Ticino, the MG2 Tekna is in an area of controlled relative humidity of 20% (rH 20% +/- 5%), has a production capability of 110,000 cps/hour and increases the CDMO’s manufacturing capacity to up to 500 million capsules per year.
Alongside the MG2 Tekna machine the company has also invested in a MultiNETT, a net weight control system that monitors and reports the net weight of each dosed capsule. The MultiNETT system employs capacitive tomography to guarantee accuracy and precision and rejects all capsules it deems out of specification.
Michael Grassberger has recently been promoted to managing director at Micro-Sphere and is spearheading the company’s plans to increase its client portfolio with its greater capacity and improved services.
He said: “Micro-Sphere has always strived to offer the best possible service to our customers. This investment is the result of increasing client demand for encapsulation services and our drive to offer customers real commercial benefits.
“This new machinery will offer high-quality products, reduced production times, detailed batch reporting and, ultimately, cost savings.
“Added to our existing Harro Höfliger drum dosing equipment the new MG2 Tekna dosator system means we are the only CDMO in the world to offer these two important commercial size filling techniques under one roof.”
This latest announcement is the final step in Micro-Sphere’s 21 million CHF (€19 million) investment plan to expand its GMP manufacturing capabilities and comes as the company celebrates its 20th year in business.
Michael added: “In all of its 20 years our company has been committed to strengthening our niche capabilities in spray drying and inhalables. The expansion has seen a significant investment of time and resource and now enables us to move forward with our planned growth and hopefully garner success for at least another 20 years.”
Chemspace and LabNetwork collaborate to extend access to chemical databases
14 Feb 2019
Collaboration provides drug discovery researchers access to European distribution and local support for library of in-stock and on-demand compounds.Read more
SGS to conduct its first malaria human challenge trial in Belgium
13 Feb 2019
The advanced candidate compound undergoing the trial has demonstrated potential to target malaria parasites before they have a chance to establish the symptoms of malaria.Read more
Post-EU FMD deadline - 'business as usual'?
12 Feb 2019
Partner connectivity will be an immediate and ongoing challenge beyond the deadline and several pharma companies are likely to break agreements with current suppliers through breach of contract clauses.Read more
BASF opens Application Technology Laboratory for personal care in Nigeria
11 Feb 2019
Local competence in application and formulation technology for sub-Saharan African personal care market.Read more
FDA approves first Nanobody-based medicine for adults with aTTP
10 Feb 2019
Cablivi is the first US approval for Sanofi's new rare blood disorders franchise.Read more
Pharmapack Europe 2019 Award Winners
7 Feb 2019
Awards showcased a wide range of industry-changing discoveries in drug delivery, packaging and automation.Read more
Brexit - the EU FMD's painful problem
7 Feb 2019
Teething problems are no stranger to the implementation of new regulations, but with the EU FMD, Brexit came like a set of wisdom teeth – late, painful and problematic.Read more
New series of advanced freeze dryers
6 Feb 2019
The LyoConstellation series allows the development of highly aggressive cycles and the mapping of the furthest reaches of theoretical design space for a formulation.Read more
Hitachi Chemical to acquire apceth Biopharma
5 Feb 2019
Acquisition will strengthen Hitachi's presence in the second-largest cell and gene therapy market in the world.Read more
FDA approves first generic Advair Diskus
4 Feb 2019
Mylan's Wixela Inhub is the first FDA-approved therapeutically equivalent generic of Advair Diskus (fluticasone propionate and salmeterol inhalation powder) for certain patients with asthma or COPD.Read more
Are you a supplier
Here's what we can do for you
- Generate quality leads for your business
- Stay visible for 365 days of the year
- Receive product inquiries and respond to meeting requests directly
- Improve company online presence through Search Engine Optimisation